Anti-leukemia activity of human gamma delta T cells

被引：5
|
作者：
Siegers, Gabrielle M. [1 ,2 ]
机构：
[1] Univ Western Ontario, Robarts Res Inst, Imaging Res Labs, London, ON, Canada
[2] Univ Toronto, Princess Margaret Hosp, Cell Therapy Program, Toronto, ON, Canada
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 02期
关键词：
gamma delta T cells; expansion protocol; preclinical investigation; in vivo bioluminescent xenograft model; adoptive cellular immunotherapy; PERIPHERAL-BLOOD; LYMPHOCYTES; LEUKEMIA;
D O I：
10.4161/onci.1.2.18231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two recently published articles from Siegers and colleagues detail both a novel human gamma delta T cell (GDTc) expansion protocol and a bioluminescent xenograft model of Ph+ leukemia, in which GDTc adoptive therapy was tested. Additionally, B-cell chronic lymphocytic leukemia-derived cells were newly identified as targets of preferentially expanded Vdelta1 GDTc.
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [1] Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
    Siegers, Gabrielle M.
    Felizardo, Tania C.
    Mathieson, A. Mark
    Kosaka, Yoko
    Wang, Xing-Hua
    Medin, Jeffrey A.
    Keating, Armand
    PLOS ONE, 2011, 6 (02):
  • [2] Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
    Van Acker, Heleen H.
    Anguille, Sebastien
    Willemen, Yannick
    Van den Bergh, Johan M.
    Berneman, Zwi N.
    Lion, Eva
    Smits, Evelien L.
    Van Tendeloo, Viggo F.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9 : 1 - 13
  • [3] Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice
    Liu, X.
    Barrett, D. M.
    Jiang, S.
    Fang, C.
    Kalos, M.
    Grupp, S. A.
    June, C. H.
    Zhao, Y.
    BLOOD CANCER JOURNAL, 2016, 6 : e430 - e430
  • [4] Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
    Rozenbaum, Meir
    Meir, Amilia
    Aharony, Yarden
    Itzhaki, Orit
    Schachter, Jacob
    Bank, Ilan
    Jacoby, Elad
    Besser, Michal J.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [5] Human gamma delta T regulatory cells in cancer: fact or fiction?
    Wesch, Daniela
    Peters, Christian
    Siegers, Gabrielle Melanie
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [6] The anti-leukemia activity and mechanisms of shikonin: a mini review
    Dong, Han
    Chang, Chun-Di
    Gao, Fei
    Zhang, Na
    Yan, Xing-Jian
    Wu, Xue
    Wang, Yue-Hui
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Apoptosis of gamma/delta T cells in human ehrlichiosis
    Caldwell, CW
    Everett, ED
    McDonald, G
    Yesus, YW
    Roland, WE
    Huang, HM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (05) : 640 - 646
  • [8] Synthesis of sinomenine derivatives with potential anti-leukemia activity
    Gao, Xiang
    Li, Hao-Nan
    Liu, Peng-Ju
    Long, Xiao-Kang
    Guo, Xue-Hai
    Hua, Hui-Ming
    Li, Da-Hong
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2024,
  • [9] Human gamma delta T Cells and Tumor Immunotherapy
    Tanaka, Yoshimasa
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2006, 46 (01) : 11 - 23
  • [10] Myricetin is a novel inhibitor of human inosine 5′-monophosphate dehydrogenase with anti-leukemia activity
    Pan, Huiling
    Hu, Qian
    Wang, Jingyuan
    Liu, Zehui
    Wu, Dang
    Lu, Weiqiang
    Huang, Jin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) : 915 - 922
12345